Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

COMP grants perifosine positive opinion as orphan medicinal product in MM

March 2, 2010

UCB presents novel PI3K inhibitors

March 2, 2010

Genentech identifies novel MEK inhibitors

March 2, 2010

AstraZeneca discloses novel FGFR inhibitors

March 2, 2010

Virginia G. Piper Cancer Center and TGen begin phase I trial of Pharmacyclics' PCI-32765 in cancer

March 1, 2010

FDA issues refuse to file letter to Adventrx on vinorelbine NDA

March 1, 2010

Novel dual PI3K alpha and mTOR inhibitors described by S*BIO

March 1, 2010

Merck KGaA identifies novel PDK1 inhibitors

March 1, 2010

Sunesis poised to begin phase III voreloxin trial in AML

Feb. 26, 2010

EMA approves OncoGenex's development plan for OGX-011

Feb. 26, 2010

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...